Form 13-F position report

PROTEOSTASIS THERAPEUTICS I

Reported by LORD ABBETT & CO LLC

PTI CUSIP 74373B109 Manager CIK 0000728100

Reported 0 shares, down 481,093 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2018
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2018

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for PROTEOSTASIS THERAPEUTICS I held by LORD ABBETT & CO LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

70 managers reported PROTEOSTASIS THERAPEUTICS I for Q2 2018.

Managers reporting PROTEOSTASIS THERAPEUTICS I in Q2 2018.
Manager Activity Shares Change % of reported 13F Reported value Tenure
NEA Management Company LLC Unchanged 5,556,778 0 0.73% $15,503,000 10 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 5,043,780 +216,220 < 0.01% $14,072,000 2 qtrs
JENNISON ASSOCIATES LLC Added 3,663,710 +41,856 < 0.01% $10,222,000 10 qtrs
BlackRock Inc Added 1,807,717 +1,760,063 < 0.01% $5,043,000 9 qtrs
VANGUARD GROUP INC Added 1,085,885 +135,558 < 0.01% $3,030,000 9 qtrs
RTW INVESTMENTS LP Reduced 1,077,408 -27,532 0.22% $3,006,000 3 qtrs
HILLHOUSE INVESTMENT MANAGEMENT LTD Unchanged 865,923 0 0.04% $2,416,000 8 qtrs
FIL Ltd Unchanged 652,316 0 < 0.01% $1,820,000 8 qtrs
BAILARD INC Added 582,400 +62,300 0.1% $1,625,000 2 qtrs
Rock Springs Capital Management LP Reduced 471,321 -203,679 0.05% $1,315,000 10 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2018
Filed
August 14, 2018
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.